An immunotherapy shot into the tumor cleared some early skin cancers in a small study
In a small phase 1 study published Oct. 30, 2026, in the Journal of the American Academy of Dermatology, low-dose cemiplimab injected into early squamous cell skin cancers left no cancer under…